We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Phosphorylation of hypothalamic AMPK on serine related to sustained weight loss by alpha-lipoic acid in mice treated with olanzapine.
- Authors
Kim, Hyunjeong; Park, Minsun; Lee, Su-Kyoung; Jeong, Jihyeon; Namkoong, Kee; Cho, Hyun-Sang; Park, Jin; Lee, Byung-In; Kim, Eosu
- Abstract
Rationale: Alpha-lipoic acid (ALA) was shown to suppress atypical antipsychotic drug (AAPD)-induced weight gain. However, its mode of action has remained unidentified. Objective: We aimed to identify mechanisms underlying anti-obesity effects of ALA in mice treated with olanzapine. Methods: We compared body weight and food intake among vehicle-, olanzapine-, and olanzapine plus ALA-treated mice, and measured hypothalamic AMP-activated protein kinase (AMPK) activity by detecting levels of Thr and Ser phosphorylation, which indicate activation and inhibition of AMPK, respectively. Results: Body weights were increased by olanzapine in parallel with increased levels of Thr phosphorylation of hypothalamic AMPK. Initially increased rate of weight gain was diminished as Thr phosphorylation levels were decreased to control levels after 10 days of olanzapine treatment. ALA successfully not only prevented olanzapine-induced weight gain but also induced additional weight loss even relative to control levels throughout the treatment period. During the initial stage, ALA's action was indicated by both suppression of olanzapine-induced Thr phosphorylation and an increase in Ser phosphorylation levels. However, in the later stage when no more increases in Thr phosphorylation and weight gain by olanzapine were observed, ALA's action was only indicated by increased levels of Ser phosphorylation. Conclusions: Our data suggest that anti-obesity effects of ALA may be related to modulation of both Ser phosphorylation and Thr phosphorylation of hypothalamic AMPK, while olanzapine-induced weight gain may be only associated with increase in Thr phosphorylation. This might be an important mechanistic clue for the future development of anti-obesity drugs beyond control of AAPD-induced weight gain.
- Subjects
PSYCHOPHARMACOLOGICAL research; LIPOIC acid; WEIGHT loss; LABORATORY mice; OLANZAPINE; PROTEIN kinases; LEPTIN; PHOSPHORYLATION; PHYSIOLOGY
- Publication
Psychopharmacology, 2014, Vol 231, Issue 20, p4059
- ISSN
0033-3158
- Publication type
Article
- DOI
10.1007/s00213-014-3540-3